Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology

Study ID
NCT02861430

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

UNMASK

Trial Summary

Unmask Trial aims to evaluate the Kappa concordance between immunochemistry and molecular biology to detecting cancer cells in sentinel lymph node in patients undergoing colectomy for non metastatic colon cancer.

More informations

Trial Starting Date

Apr 30,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

388